CPT code 55715 is an add-on code for image-guided targeted prostate biopsy performed on an additional lesion beyond the initial target. It captures procedures that employ MRI–ultrasound fusion or in‑bore CT/MRI guidance to obtain tissue from a discrete prostate lesion. Nationally, accurate coding for targeted biopsy add-ons affects procedural reporting, quality measurement, and appropriate aggregation of diagnostic services for prostate cancer evaluation.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines how payers typically recognize add-on image-guided biopsy services and how CPT code 55715 fits alongside primary biopsy codes.

Readers will learn the clinical context for using CPT code 55715, the typical sites of service where the procedure is performed, and the coding role of the add-on for each additional lesion sampled. The report summarizes benchmarks and reimbursement context at a national level, highlights policy considerations relevant to payers and providers, and clarifies documentation elements that support reporting this add-on code. Where input fields were not provided, this summary notes that specific payer policies, modifiers, taxonomies, and ICD-10 pairings are not available in the input.